Markets:

Overview

News

Currencies

International

Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

140.05 +0.66 (+0.47%)

Streaming Delayed Price Updated: 3:39 PM EDT, Jun 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Bearish Shooting Star Shines ↗

July 13, 2024

Following signs of resistance in biotech ETF XBI on Friday, a shooting star forms. A bearish retracement may take hold soon..

Via Talk Markets

Topics ETFs

AskSlim Market Week - Friday, July 12 ↗

July 12, 2024

An analysis and commentary on the financial markets.

Via Talk Markets

Stocks Are Breaking Down Beneath The Surface ↗

July 09, 2024

Stocks and sectors are showing real signs of weakness despite the headline indexes going higher.

Via Talk Markets

Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗

July 08, 2024

Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.

Via Talk Markets

Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows ↗

July 01, 2024

June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while utilities lagged.

Via Benzinga

Topics ETFs

AskSlim Market Week - Friday, March 28 ↗

March 28, 2024

An analysis and commentary on the financial markets.

Via Talk Markets

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More ↗

June 24, 2024

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

Via Benzinga

Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React ↗

June 12, 2024

U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September.

Via Benzinga

Topics Economy

Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO ↗

June 10, 2024

Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services.

Via Talk Markets

June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge ↗

June 05, 2024

Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024.

Via InvestorPlace

American Express, Trade Desk And More: CNBC's 'Final Trades' ↗

June 04, 2024

American Express Company has "above market growth for below market multiple," Amy Raskin of Chevy Chase Trust said.

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy in June 2024 ↗

June 04, 2024

https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate

Via InvestorPlace

Should I Be Worried? Stock Market (And Sentiment Results)… ↗

May 30, 2024

We are aggressively putting money to work in individual companies that are excessively undervalued relative to what we believe their normalized earnings power will look like as their recoveries...

Via Talk Markets

If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names ↗

May 29, 2024

Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.

Via InvestorPlace

Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks ↗

May 24, 2024

Investors have been ignoring biotech stocks for far too long. Here's why they could start to heat up in 2024.

Via InvestorPlace

For Biotech Stocks To Move Higher, This Must Move Lower ↗

May 15, 2024

While biotechs have significantly lagged behind the broader market, there is reason to be optimistic once inflation-related volatility subsides. IBB and XBI present good vehicles for biotech exposure.

Via Talk Markets

Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential' ↗

May 09, 2024

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

Via Benzinga

AskSlim Market Week - Friday, April 26 ↗

April 26, 2024

An analysis and commentary on the financial markets.

Via Talk Markets

3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition ↗

April 25, 2024

Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.

Via InvestorPlace

Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead ↗

April 16, 2024

Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.

Via Talk Markets

Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns ↗

April 04, 2024

Stocks initially rose on positive jobless claims report, but dropped later as Fed officials expressed doubts about interest rate cuts this year.

Via Benzinga

Topics Economy

5 Healthcare Stocks to Buy for 2024 ↗

April 02, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

Via InvestorPlace

Topics Artificial Intelligence

Healthcare And Biotech Stocks Review: Q1 2024 Performance ↗

April 01, 2024

We just had one of the best first quarters in recent market history since Q1 in 2019 when the market was up 13%. But changes in sector performance may be coming. The S&P 500 was up 10% showing a slight...

Via Talk Markets

Topics Stocks

2 Top Biotech Buyout Candidates ↗

March 31, 2024

Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...

Via Talk Markets

3 Top ETFs I Plan to Buy in April ↗

March 31, 2024

These ETFs are easy, low-cost ways to invest in certain themes.

Via The Motley Fool

Topics ETFs

3 Biotech Stocks to Buy on the Dip: March 2024 ↗

March 27, 2024

Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.

Via InvestorPlace

Tuesday Talk: Big-Tech Under Attack ↗

March 26, 2024

On Thursday the Justice Dept. filed an antitrust suit against Apple. The suit joins two others already filed against Google. How much this will affect the market in the long run is up for grabs.

Via Talk Markets

Biotechnology And Healthcare, A Bit Of A Lull ↗

March 25, 2024

Strong momentum of Tech and Chip stocks may be too good of a distraction for biotech investors.

Via Talk Markets

3 Biotech ETFs Overdue for a Bounce ↗

March 19, 2024

The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback.

Via InvestorPlace

Topics ETFs

It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility ↗

March 11, 2024

Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.